- $1.22bn
- $1.27bn
- $606.88m
Opko Health Inc Expected To Post A Loss Of 9 Cents A Share: Earnings Preview
Opko Health Inc Expected To Post A Loss Of 9 Cents A Share: Earnings Preview
Factbox: Drugmakers deepen efforts to tap into booming market for obesity drugs
Brief: NextPlat Receives Initial Approvals To Launch OPKO Health on Alibaba's Tmall Global Platform in China
Brief: Opko Health Announces Pricing Of Private Offering Of $200 Million Convertible Senior Notes Due 2029
U.S. STOCKS ON THE MOVE-Crypto stocks, US insurers, EPAM Systems
U.S. STOCKS ON THE MOVE-Apple, Lamb Weston, Dyne Therapeutics
U.S. STOCKS ON THE MOVE-Home Depot, Dollar General, Conagra
Opko Health tumbles on convertible debt deal
Brief: OPKO Health Announces Private Offering Of Convertible Senior Notes Due 2029
Factbox: Roche enters obesity drugs race with $2.7 bln Carmot deal
Factbox: Roche enters obesity drugs race with $2.7 bln Carmot deal
Factbox: Pfizer's weight loss ambitions hit roadblock
Brief: OPKO Health Q3 Net Income USD -84.5 Million
Opko Health Inc Expected To Post A Loss Of 10 Cents A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Mercato, Baytex, Ball Corp
U.S. STOCKS ON THE MOVE-SeaStar, Sigma Lithium, Brinker
U.S. STOCKS ON THE MOVE-OPKO Health, Structure Therapeutics, Blue Apron
OPKO Health up after unit awarded BARDA contract